arrow
N

Nikos Darzentas

second medical department
H指数:36
被引数:5,184
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Proteomic and proteogenomic identification of targetable T-cell antigens in multiple myeloma

多发性骨髓瘤中可靶向T细胞抗原的蛋白质组学和蛋白质基因组学鉴定

2026-07-280
OA
ctDNA dynamics demonstrates rapid treatment response to tafasitamab + R-CHOP +/− lenalidomide and predicts outcome in diffuse large B-cell lymphoma: results from the phase 1b First-MIND study

ctDNA动力学证明了tafasitamab + R-CHOP +/- lenalidomide的快速治疗反应,并能预测弥漫性大B细胞淋巴瘤的结局:First-MIND 1b期研究结果

Leukemia
IF13.4
2025-10-270
OA
C/EBP Family Member Gene Fusions and Cooperating Genomic Events Define Two Distinct Molecular Sub-Groups in Adult B Precursor ALL

C/EBP家族成员基因融合及协同基因组事件定义了成人B细胞前体急性淋巴细胞白血病中的两个不同分子亚组

BLOOD
IF23.1
2024-11-050
PRE
EuroClonality-NGS Recommendations for Evaluation of B-Cell Clonality Analysis by Next-Generation Sequencing A Structured Approach with the DEPART Algorithm
2023-10-013
OAAI
Next-Generation Sequencing-Based Clonality Assessment of Ig Gene Rearrangements A Multicenter Validation Study by EuroClonality-NGS
2021-09-0128
OAAI
The presence of CLL-associated stereotypic B cell receptors in the normal BCR repertoire from healthy individuals increases with age
2019-08-2819
OAAI
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study

免疫球蛋白和T细胞受体基因重组的标准化下一代测序用于急性淋巴细胞白血病的MRD标记鉴定; 欧洲克隆性-NGS验证研究

LEUKEMIA
IF13.4
2019-06-26175
OAAI